Nectar Lifescience Ltd

We wish to inform you that the Board of Directors in their meeting held on May 26 2023 have inter- alia decided and approved the following:Audited Financial Results:Pursuant to the Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR Regulation) the following documents are enclosed: Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2023; Auditors Reports thereon; Statement of Assets and Liabilities (Standalone and Consolidated) as at March 31 2023; Cash Flow Statement (Standalone and Consolidated) for the year ended March 31 2023; Certificate for unmodified opinion.;